# Loretta M. Itri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/loretta-m-itri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,145 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 45 |
| i10-index | 66 |
| Last Known Institution | BioScience Laboratories (United States) |
| OpenAlex ID | https://openalex.org/A5061549536 |
| Works | 108 |

## Researcher papers

- [Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer](https://scholariq.org/papers/sacituzumab-govitecan-in-metastatic-triple-negative-breast-cancer/)
- [TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors](https://scholariq.org/papers/trophy-u-01-a-phase-ii-open-label-study-of-sacituzumab-govitecan-in-patients/)
- [Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer](https://scholariq.org/papers/biomarker-analyses-in-the-phase-iii-ascent-study-of-sacituzumab-govitecan-versus/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Retinoids in leukemia and cellular processes](https://scholariq.org/topics/retinoids-in-leukemia-and-cellular-processes/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [BioScience Laboratories (United States)](https://scholariq.org/institutions/bioscience-laboratories-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.